Furazolidone-based Therapies for Helicobacter pylori Infection: A Pooled-data Analysis

BACKGROUND/AIM: Furazolidone-based therapies are used in developing countries to cure Helicobacter pylori infection due to its low cost. The low bacterial resistance toward furazolidone may render appealing the use of this drug even in developed countries. However, some relevant safety concerns do e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zullo, Angelo, Ierardi, Enzo, Hassan, Cesare, Francesco, Vincenzo De
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271687/
https://www.ncbi.nlm.nih.gov/pubmed/22249086
http://dx.doi.org/10.4103/1319-3767.91729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271687/
https://www.ncbi.nlm.nih.gov/pubmed/22249086
http://dx.doi.org/10.4103/1319-3767.91729

Ejemplares similares